MLTX
Price
$13.39
Change
-$0.01 (-0.07%)
Updated
Nov 19, 01:51 PM (EDT)
Capitalization
950.06M
99 days until earnings call
Intraday BUY SELL Signals
QURE
Price
$27.93
Change
-$1.79 (-6.02%)
Updated
Nov 19, 01:57 PM (EDT)
Capitalization
1.85B
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLTX vs QURE

Header iconMLTX vs QURE Comparison
Open Charts MLTX vs QUREBanner chart's image
MoonLake Immunotherapeutics
Price$13.39
Change-$0.01 (-0.07%)
Volume$200
Capitalization950.06M
uniQure
Price$27.93
Change-$1.79 (-6.02%)
Volume$550
Capitalization1.85B
MLTX vs QURE Comparison Chart in %
MLTX
Daily Signal:
Gain/Loss:
QURE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MLTX vs. QURE commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and QURE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (MLTX: $13.41 vs. QURE: $29.68)
Brand notoriety: MLTX and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 54% vs. QURE: 33%
Market capitalization -- MLTX: $950.06M vs. QURE: $1.85B
MLTX [@Biotechnology] is valued at $950.06M. QURE’s [@Biotechnology] market capitalization is $1.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, both MLTX and QURE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while QURE’s TA Score has 5 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 4 bearish.
  • QURE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than QURE.

Price Growth

MLTX (@Biotechnology) experienced а +14.13% price change this week, while QURE (@Biotechnology) price change was -3.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

MLTX is expected to report earnings on Feb 26, 2026.

QURE is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($1.85B) has a higher market cap than MLTX($950M). QURE YTD gains are higher at: 68.063 vs. MLTX (-75.235). QURE has higher annual earnings (EBITDA): -119.56M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. QURE (377M). QURE has less debt than MLTX: QURE (66.7M) vs MLTX (75.8M). QURE has higher revenues than MLTX: QURE (14.3M) vs MLTX (0).
MLTXQUREMLTX / QURE
Capitalization950M1.85B51%
EBITDA-196.98M-119.56M165%
Gain YTD-75.23568.063-111%
P/E RatioN/AN/A-
Revenue014.3M-
Total Cash425M377M113%
Total Debt75.8M66.7M114%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
89
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXQURE
RSI
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 13 days ago
76%
Declines
ODDS (%)
Bearish Trend 22 days ago
73%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signal:
Gain/Loss:
QURE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLDIX9.65N/A
N/A
BlackRock Managed Income Institutional
ARAIX75.13N/A
N/A
Ariel Fund Institutional
AQEIX18.49N/A
N/A
LKCM Aquinas Catholic Equity
DBOAX25.82N/A
N/A
BNY Mellon Balanced Opportunity A
MLGRX8.71-0.09
-1.02%
NYLI Winslow Large Cap Growth Class R3

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+3.23%
KALA - MLTX
88%
Closely correlated
-1.46%
IOBT - MLTX
76%
Closely correlated
+25.10%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
+2.62%
NUVL - MLTX
48%
Loosely correlated
-3.48%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NEVPF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
-2.14%
NEVPF - QURE
50%
Loosely correlated
N/A
AXON - QURE
42%
Loosely correlated
-1.74%
LXEO - QURE
40%
Loosely correlated
-3.06%
MLTX - QURE
37%
Loosely correlated
+3.23%
SNGX - QURE
36%
Loosely correlated
+2.59%
More